$TPAC (Updated 12/8/15)Here is a company with no

New Post Public Reply Private Reply Replies (0) Message Board
Mysterium
$TPAC (Updated 12/8/15)Here is a company with no convertible debt and that has stated repeatedly that it will not R/S unless to uplist while already in a position of strength; company will also not take on any new convertible notes. There is a wealth of information on TPAC to take heed of, some of which I will provide and other info which can be turned up doing your own independent research as I have. On top of being a stock free of toxic financing and that will not R/S, we have a CEO that communicates regularly with shareholders via email and Twitter.

Bill McKay, CEO, strikes me as a gentleman and a person of integrity, something rarely seen in the OTC. The management team here consists of many aerospace veterans with ties to the major players in the field. Bill was also CEO and founder of Harbin and of CEO Acromil Corporation: http://www.acromil.com/ He is a B.A., J.D., and M.B.A. His bio can be found on the 'Management Team' link pasted below.

Greg Archer, Director for TPAC, spent 24 years as an executive with Northrup Grumman. While this is impressive, both in terms of loyalty and position, it is the connection to the higher-ups in supply and procurement that matter, seeing as Northrup just won the Pentagon bid - for the first time in decades - to an $80B dollar bomber contract for the Navy and Air Force(see 'Bomber Contract' link below).

In order to sell to the govt., a company needs a CAGE code. TPAC has one. In order to sell aerospace parts, NAVAIR certification is needed. We are one of only six companies in the U.S. that is NAVAIR certified, and the only one company in China that has NAVAIR cert. China just announced COMAC's 174 passenger C919 as competitor to U.S. counterparts Boeing and Airbus. We are also the only producer of self-lubricating bearings in China and thus serve to provide them with deep discounts on importation and taxes. Our bearings are approved at 25k rotations and are soon to be tested at 100k rotations, with degradation rate at the aforementioned turns being less than the thickness of a human hair. We also have a few very coveted aerospace certs: SAE-AS 81820 and SAE-AS 81934. As a quick aside, NAVAIR takes, on average, 5yrs and several million dollars - not to mention patience and meticulous completion of paperwork - to acquire; we have.

In the works are two acquisitions and a joint venture. Upon completion of the acquisitions, Mr. McKay will be buying back $2M in TPAC common shares. We are also looking at purchase orders of varying sizes coming down the pipeline. Many parts have already been trialed and some have already received approval. Substantive PR to come. (See Twitter conversation below).
****Update 12/8/15 TPAC Begins 1.8B Share Buyback: http://www.marketwatch.com/story/trans-pacifi...2015-12-09 *****

'Management Team': http://tpacbearings.com/management-team

'Bomber Contract': http://www.theatlantic.com/politics/archive/2...rs/412720/

Post with link to CAGE code for verification:
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 8

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 10

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 4

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise and Fall of MedMen's Cannabis Empire

Updated Category News Views 178

Let's slice through the smoke and mirrors of MedMen's saga—a story that captures the dizzying heights and staggering lows of what was once the poster child for America's cannabis gold rush. The buzz is about a documentary from Bungalow Media + Entertainment that’s gearing up to pull back the curtain on Adam Bierman and his rollercoaster ride with MedMen. They kicked...

Continue Reading
Draganfly Secures $25 Million for Innovative Drone Solutions

Updated Category News Views 136

Overview of Recent Financial Activities Draganfly Inc. (NASDAQ: DPRO), a leader in drone technology and robotics, has made significant strides in its financial landscape by securing a registered direct offering. This initiative is designed to enhance their operational capabilities and support new product developments. Details of the Direct Offering In a recent...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 304

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
iHerb's Chief Operating Officer Miriee Chang Set to Retire

Updated Category News Views 196

iHerb Announces Retirement of COO Miriee Chang iHerb, a global leader in online retail for wellness products, has announced the planned retirement of Chief Operating Officer Miriee Chang. This change marks a significant transition for the company, dedicated to maintaining its operational excellence and customer service quality. Continuity During the Transition Miriee...

Continue Reading
Liberty Broadband to Reveal Q4 2024 Performance in Upcoming Call

Updated Category News Views 103

Liberty Broadband Corporation's Upcoming Conference Call Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) is gearing up for a significant event as it prepares to hold a conference call to unveil its financial results for the fourth quarter of 2024. This highly anticipated call is set to take place soon, providing an opportunity for stakeholders and interested...

Continue Reading